isoproterenol has been researched along with stachydrine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Z; Sang, M; Wu, D; Wu, Q; Xu, Y; Zhao, L | 1 |
1 other study(ies) available for isoproterenol and stachydrine
| Article | Year |
|---|---|
Stachydrine ameliorates isoproterenol-induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF-κB and JAK/STAT signaling pathways in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiomegaly; Cytokines; Isoproterenol; Janus Kinase 2; Male; NF-kappa B; Oxidative Stress; Proline; Rats, Sprague-Dawley; Signal Transduction; STAT3 Transcription Factor | 2017 |